Nasus Pharma NSRX
NYSE NSRX
$3.38 +0.13 (+4.20%)
As of: Oct 21, 2026 · 2:12 PM EDT

Nasus Pharma (NSRX) Payables (2024 - 2026)

Updated

Nasus Pharma (NSRX) reported Payables of $347,000 for Q2 2026, down 47.7% from $664,000 a year earlier.

Analysis

Nasus Pharma (NSRX) Payables (2024 - 2026) Analysis & Trends

At the end of FY2025, Nasus Pharma posted Payables of $829,000, down 16.0% from FY2024.

  • By year, Payables came in at $987,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Eli Lilly 1,138.33 Bn 1,106.91 Bn 19.71 Bn 6.11 Bn
2 Johnson & Johnson 618.82 Bn 537.35 Bn 17.26 Bn 20.92 Bn
3 AbbVie 503.36 Bn 476.47 Bn 12.70 Bn 33.30 Bn
4 Merck 369.59 Bn 323.96 Bn 12.21 Bn 5.96 Bn
5 Novartis Ag 298.57 Bn 262.56 Bn 11.24 Bn 4.26 Bn
6 Astrazeneca 261.25 Bn 234.94 Bn 12.86 Bn 22.89 Bn
7 Amgen 237.35 Bn 192.75 Bn 7.24 Bn 2.87 Bn
8 Gilead Sciences 191.27 Bn 165.47 Bn 6.22 Bn 674.00 Mn
9 Pfizer 170.03 Bn 116.68 Bn 10.94 Bn 7.03 Bn
10 Nasus Pharma 27.03 Mn 10.33 Mn - 347,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 347,000.00
Dec 31, 2025 829,000.00
Jun 30, 2025 1.18 Mn
Dec 31, 2024 987,000.00
API Access

Nasus Pharma Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=payables&ticker=NSRX&period=max&api_key=YOUR_API_KEY